Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 February 2023
|
| In: |
BMC health services research
Year: 2023, Volume: 23, Pages: 1-17 |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-023-09095-2 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12913-023-09095-2 |
| Author Notes: | Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos |
| Summary: | New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear. |
|---|---|
| Item Description: | Gesehen am 17.04.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-023-09095-2 |